A Study to Enroll Patients of Rheumatic Diseases and First-degree Relatives in a Biobank

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 14-000616
    Sponsor Protocol Number: 14-000616

About this study

The purpose of this study is to enroll rheumatic disease patients and first-degree relatives in a biobank, and to follow them over time to assess health outcomes and collect additional specimens.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria

  • Adult patients ≥ 18 years of age
  • Must be able to provide informed consent
  • Diagnosis of a rheumatic disease by a rheumatologist, ie 
    • Rheumatoid arthritis
    • Psoriatic arthritis
    • Ankylosing spondylitis
    • Arthritis associated with inflammatory bowel disease
    • Undifferentiated spondyloarthritis
    • Systemic lupus erythematosus
    • Sjogren’s syndrome
    • Scleroderma/systemic sclerosis
    • Polymyositis
    • Dermatomyositis
    • Mixed connective tissue disease
    • Granulomatosis with polyangiitis
    • Microscopic polyangiitis
    • ANCA-associated vasculitis
    • Giant cell arteritis
    • Takayasu arteritis
    • Polyarteritis nodosa
    • Drug-induced rheumatic disorders
  • First-degree relative of a patient with a diagnosis of a rheumatic disease

 

Exclusion Criteria

  • Individuals who do not comprehend English 
    • Participants must be able to read and sign a consent form without the assistance of an interpreter
  • Individuals who are unable to sign consent
    • mentally challenged
    • declared legally incompetent
  • Individuals regarded as belonging to a vulnerable population
    • prisoners

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Davis, M.D.

Open for enrollment

Contact information:

Jennifer Sletten

(507)284-3695

Sletten.Jennifer@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20207284

Mayo Clinic Footer